NOT KNOWN DETAILS ABOUT HEMGENIX

Amount of suitable individuals: CDEC talked over the uncertainty in the amount of sufferers with moderately serious to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical authorities consulted by CADTH indicated that some people who're categorised as owning delicate or moderate condition could possibly have a severe blee